Protocol summary

Study aim
determine the effect of different doses of vitamin D3 supplementation on anthropometric indexes, parameters of metabolic, bone, vascular and body composition in children and adolescents with overweight or obesity
Design
parallel group, single blind, randomized placebo-controlled clinical trial.
Settings and conduct
overweight and obesity children and adolescents of Tehran, Iran
Participants/Inclusion and exclusion criteria
Inclusion criteria: - Willingness to cooperate - Age 6-13 years - Overweight or obesity Exclusion criteria: - Reluctance to cooperate in any stage of study - Use of any vitamin D supplements - Use of any drugs, affecting metabolism of vitamin D including glucocorticoids, steroids and anticonvulsants such as carbamazepine, phenytoin and phenobarbital
Intervention groups
Three intervention groups as follows:oral 2000 IU of vitamin D3 supplement, 1000 IU vitamin D3 supplement, and the control group (600 IU vitamin D3 supplement) for 12 months.
Main outcome variables
carotid intima media thickness (cIMT), 25 hydroxy vitamin D, parathormone, lipid profile, glucose, insulin, body mass index, fat mass, lean mass, systolic and diastolic blood pressure, calcium, phosphorus

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20180805040703N1
Registration date: 2018-10-20, 1397/07/28
Registration timing: retrospective

Last update: 2018-10-20, 1397/07/28
Update count: 0
Registration date
2018-10-20, 1397/07/28
Registrant information
Name
Golaleh Asghari
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2240 9309
Email address
g_asghari@hotmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2016-06-20, 1395/03/31
Expected recruitment end date
2017-03-12, 1395/12/22
Actual recruitment start date
2016-06-20, 1395/03/31
Actual recruitment end date
2017-03-12, 1395/12/22
Trial completion date
2018-08-21, 1397/05/30
Scientific title
Effects of different dosages of vitamin D3 on anthropometric indices, metabolic, bone, and vascular parameters and body composition in overweight or obese children and adolescents
Public title
Effects of different dosages of vitamin D3 on anthropometric indices, metabolic, bone, and vascular parameters and body composition
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Willingness to cooperate Age 6-13 years Overweight or obesity (BMI ≥ 85th percentile national scale by age and sex)
Exclusion criteria:
Reluctance to cooperate in any stage of study Use of any vitamin D supplements during the last six months Identifying any types of liver diseases, kidney, cardiovascular and metabolic bone Use of any drugs, affecting metabolism of vitamin D including glucocorticoids, steroids and anticonvulsants such as carbamazepine, phenytoin and phenobarbital Following any weight loss diets during the past one year
Age
From 6 years old to 13 years old
Gender
Both
Phase
3
Groups that have been masked
  • Investigator
Sample size
Target sample size: 327
Actual sample size reached: 378
Randomization (investigator's opinion)
Randomized
Randomization description
Children and adolescents will be randomized using stratified block randomization method in each intervention group (2000 IU vitamin D, 1000 IU vitamin D, and 600 IU vitamin D), before which important confounders including sex (boy or girl), body mass index (overweight or obesity), and pubertal stage (pre-puberty and puberty) are determined. Eight strata including 3-blocks of A, B and C (3 intervention groups) are determined (ABC, BCA, CAB, ACB, BAC, CBA). Thus, at the end of the study, the three therapeutic groups in terms of confounding factors, including sex, body mass index, and pubertal stage will be the same and with an equal number of subjects.
Blinding (investigator's opinion)
Single blinded
Blinding description
in this study participants were aware of dosage of vitamin D supplementation they received. but, the investigator was blind for randomization of participants. so there was no awareness of the dose received by each person.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
institutional ethics committee of the Research Institute for Endocrine Sciences, affiliated to the S
Street address
No.24, Parvaneh Ave., Yaman str., Velenjak Blvd., Chamran High way
City
Tehran
Province
Tehran
Postal code
1985717413
Approval date
2016-07-19, 1395/04/29
Ethics committee reference number
IR.SBMU.ENDOCRINE.REC.1395.213

Health conditions studied

1

Description of health condition studied
over weight and obesity, cardiovascular disease
ICD-10 code
E66
ICD-10 code description
Overweight and obesity

2

Description of health condition studied
vitamin D deficiency
ICD-10 code
E55
ICD-10 code description
Vitamin D deficiency

Primary outcomes

1

Description
carotid intima media thickness
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
sonography

Secondary outcomes

1

Description
25 hydroxy vitamin D
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
Electrochemiluminescence

2

Description
para thyroid hormon
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
Electrochemiluminescence

3

Description
plasma insulin
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
Electrochemiluminescence

4

Description
plasma glucose
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
colorimetry

5

Description
lipid profile
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
colorimetry

6

Description
body mass index
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
calculation

7

Description
fat mass
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
bioimpedance analysis

8

Description
lean mass
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
bioimpedance analysis

9

Description
systolic and diastolic blood pressure
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
Sphygmomanometer

10

Description
calcium
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
colorimetry

11

Description
phosphorus
Timepoint
before intervention, 6 and 12 months after intervention
Method of measurement
colorimetry

Intervention groups

1

Description
Intervention group1: 12 months oral vitamin D supplementation of 2000 IU/d (ZAHRAVI pharmaceutical company-Tabriz-Iran)
Category
Prevention

2

Description
Intervention group2: 12 months oral vitamin D supplementation of 1000 IU/d (ZAHRAVI pharmaceutical company-Tabriz-Iran)
Category
Prevention

3

Description
Control group: 12 months oral vitamin D supplementation of 600 IU/d (ZAHRAVI pharmaceutical company-Tabriz-Iran)
Category
N/A

Recruitment centers

1

Recruitment center
Name of recruitment center
Institute for Endocrine Science, Shahid Beheshti university of medical sciences
Full name of responsible person
Golaleh Asghari
Street address
No.24, Parvane Ave., Yaman Str., velenjak Blvd., chamran high way
City
Tehran
Province
Tehran
Postal code
1985717413
Phone
+98 21 2243 2503
Email
g_asghari@hotmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Institute for Endocrine Science
Full name of responsible person
Fereidoun Azizi
Street address
No.24, Parvane Ave., Yaman str., Velenjak Blvd., Chamran high way
City
Tehran
Province
Tehran
Postal code
1985717413
Phone
+98 21 2243 2569
Email
azizi@erc-iran.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Institute for Endocrine Science
Proportion provided by this source
100
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Institute for Endocrine Science
Full name of responsible person
Golaleh Asghari
Position
senior researcher
Latest degree
Master
Other areas of specialty/work
Nutrition
Street address
No 24 parvane Ave., Yaman Blvd., Velenjak Str., Chamran High way
City
tehran
Province
Tehran
Postal code
1985717413
Phone
+98 21 2243 2503
Email
g_asghari@hotmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Institute for Endocrine Science
Full name of responsible person
Golaleh Asghari
Position
senior researcher
Latest degree
Master
Other areas of specialty/work
Nutrition
Street address
No.24, Parvane ave., Yaman Blvd., Velenjak str., Chamran high way
City
tehran
Province
Tehran
Postal code
1985717413
Phone
+98 21 2243 2503
Email
g_asghari@hotmail.com

Person responsible for updating data

Contact
Name of organization / entity
Institute for Endocrine Science
Full name of responsible person
Golaleh Asghari
Position
senior researcher
Latest degree
Master
Other areas of specialty/work
Nutrition
Street address
No 24, Parvaneh Ave., Yaman Blvd., Velenjak Str., Chamran High way
City
tehran
Province
Tehran
Postal code
1985717413
Phone
+98 21 2243 2503
Email
g_asghari@hotmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...